Australia Considers Changes To Bioequivalence Requirements For Foreign Comparators
Executive Summary
Changing Australian requirements on showing equivalence with an overseas reference product used in bioequivalence studies, and introducing a new early scientific advice service for biowaiver proposals, are among key proposals made by the Therapeutic Goods Administration as part of reforms in the generic medicines sector.
You may also be interested in...
Australian Reform Is Opportunity For International Work-Sharing On Non-Biological Complex Drugs
Plans to streamline the approval of generic medicines in Australia must include measures to ensure that safe and effective similar versions of non-biological complex medicines are available.
Australian Generics Approval Reform Is Opportunity For International Work-Sharing On Non-Biological Complex Drugs
Plans to streamline the approval of generic medicines in Australia must include measures to ensure that safe and effective similar versions of non-biological complex medicines are available.
Australia’s Generics Plan Could Hit Safety Standards, Warns R&D Industry Body
Medicines Australia has expressed concern over the Therapeutic Goods Administration's proposals to streamline the approval process for generics and tackle drug shortages, saying some of the ideas being considered could have the effect of bringing down safety standards.